Many Physicians at Large Cancer Centers Help Manage Care for Individuals With Neuroendocrine Tumor

Conference|NANETS Annual Multidisciplinary NET Medical Symposium

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses how large cancer centers are able to manage care for individuals with many different physicians.

In a Pharmacy Times® interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.

She discussed how large cancer centers are able to manage care for individuals with many different physicians.

Related Videos
Credit: thodonal - stock.adobe.com
Credit: Lars Neumann - stock.adobe.com
Image Credit: Adobe Stock - peterschreiber.media
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Related Content

Trastuzumab Deruxtecan Demonstrates Responses Across Advanced Solid Tumors With HER2 Expression

June 6th 2023

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

June 23rd 2022

Nivolumab-AVD Poised to be New Standard of Care for Hodgkin Lymphoma in Both Adults, Pediatric Patients

June 6th 2023

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

May 31st 2022

Long-term Data Show Efficacy of Amivantamab-vmjw Combination for Patients With Mutated Advanced Non-Small Cell Lung Cancer

June 5th 2023

Overall Survival of Patients With Metastatic NSCLC Sustained Up to 4 Years With Opdivo, Yervoy Combination

June 5th 2023

Trastuzumab Deruxtecan Demonstrates Responses Across Advanced Solid Tumors With HER2 Expression

June 6th 2023

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

June 23rd 2022

Nivolumab-AVD Poised to be New Standard of Care for Hodgkin Lymphoma in Both Adults, Pediatric Patients

June 6th 2023

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

May 31st 2022

Long-term Data Show Efficacy of Amivantamab-vmjw Combination for Patients With Mutated Advanced Non-Small Cell Lung Cancer

June 5th 2023

Overall Survival of Patients With Metastatic NSCLC Sustained Up to 4 Years With Opdivo, Yervoy Combination

June 5th 2023

Trastuzumab Deruxtecan Demonstrates Responses Across Advanced Solid Tumors With HER2 Expression

June 6th 2023

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

June 23rd 2022

Nivolumab-AVD Poised to be New Standard of Care for Hodgkin Lymphoma in Both Adults, Pediatric Patients

June 6th 2023

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

May 31st 2022

Long-term Data Show Efficacy of Amivantamab-vmjw Combination for Patients With Mutated Advanced Non-Small Cell Lung Cancer

June 5th 2023

Overall Survival of Patients With Metastatic NSCLC Sustained Up to 4 Years With Opdivo, Yervoy Combination

June 5th 2023
© 2023 MJH Life Sciences

All rights reserved.